cambridge's bluebird bio licenses delivery tech to novartis, gsk
.
.
.
.
novartis india appoints milan paleja as vice chairman and md
.
.
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital.
.